Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout

This study has been completed.

Study NCT00111657 Information provided by Duke University

First Received: May 24, 2005 Last Updated: July 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)